Additional file 1 of Whole exome sequencing-based homologous recombination deficiency test for epithelial ovarian cancer

Supplementary Fig. 1. Kaplan-Meier analysis of overall survival in training group of EOC. (A) OS of EOC patients stratified by surgical resection status. Note: EOC patients who underwent R0 resection had better OS than those who underwent R1 resection (p = 0.013, log-rank test). (B) OS of EOC patients stratified by our WES-based scarHRD test. Note: No significant difference was noted in EOC patients with a positive or negative HRD status. (C) OS of EOC patients stratified by Myriad MyChoice® CDx test Note: No significant difference was noted in EOC patients with a positive or negative HRD status

Institutions

Publication Details

Journal
Figshare
Published
2025-01-01
DOI
https://doi.org/10.6084/m9.figshare.28320569.v1
Primary Topic
PARP inhibition in cancer therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Additional file 1 of Whole exome sequencing-based homologous recombination deficiency test for epithelial ovarian cancer

Figshare
PARP inhibition in cancer therapy
article

Additional file 1 of Whole exome sequencing-based homologous recombination deficiency test for epithelial ovarian cancer

article en

Abstract

Supplementary Fig. 1. Kaplan-Meier analysis of overall survival in training group of EOC. (A) OS of EOC patients stratified by surgical resection status. Note: EOC patients who underwent R0 resection had better OS than those who underwent R1 resection (p = 0.013, log-rank test). (B) OS of EOC patients stratified by our WES-based scarHRD test. Note: No significant difference was noted in EOC patients with a positive or negative HRD status. (C) OS of EOC patients stratified by Myriad MyChoice® CDx test Note: No significant difference was noted in EOC patients with a positive or negative HRD status

Figshare
National Taiwan University (TW), National Taiwan University Hospital (TW)
Good health and well-being
Openalex Percentile: Top 42%
PARP inhibition in cancer therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.